Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Depatuxizumab mafodotin治疗EGFR扩增型新诊断胶质母细胞瘤:一项III期随机临床试验
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noac173
Lassman, Andrew B; Pugh, Stephanie L; Wang, Tony J C; Aldape, Kenneth; Gan, Hui K; Preusser, Matthias; Vogelbaum, Michael A; Sulman, Erik P; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian S; Gilbert, Mark R; Bain, Earle E; Blot, Vincent; Ansell, Peter J; Samanta, Suvajit; Kundu, Madan G; Armstrong, Terri S; Wefel, Jeffrey S; Seidel, Clemens; de Vos, Filip Y; Hsu, Sigmund; Cardona, Andrés F; Lombardi, Giuseppe; Bentsion, Dmitry; Peterson, Richard A; Gedye, Craig; Bourg, Véronique; Wick, Antje; Curran, Walter J; Mehta, Minesh P